Stockscreener 앱 받기
37.41
0.82%
-0.31
시간 외 거래:
37.30
-0.11
-0.29%
Exelixis Inc 주식(EXEL)의 최신 뉴스
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc.EXEL - PR Newswire
LPL Financial LLC Increases Position in Exelixis, Inc. (NASDAQ:EXEL) - Defense World
ATTENTION EXEL Shareholders: Lost Money on Exelixis, Inc.? Contact Levi & Korsinsky About Investigation - ACCESS Newswire
Ongoing Securities Investigation into Exelixis, Inc. (EXEL)Contact Levi & Korsinsky - ACCESS Newswire
Exelixis’ CABOMETYX Receives EU Approval for Neuroendocrine Tumor Treatment - Insider Monkey
Is Exelixis Inc. stock bottoming outPre-Market Stock Movement Summary and Review - Newser
Exelixis reports Q2 net product revenues 2% below consensus estimate. - AInvest
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Exelixis, Inc. - EXEL - GlobeNewswire Inc.
Identifying reversal signals in Exelixis Inc.Trend Confirmation Scanner with Entry Focus - Newser
Relative strength of Exelixis Inc. in sector analysisProfit Target Planning with Exit Confidence - Newser
Can Exelixis Inc. be recession proofTriple Digit Stock Opportunities - sisaissue.com
Live market analysis of Exelixis Inc.Free Daily Growth Stock Pick Reports - Newser
Lost Money on Exelixis, Inc. (EXEL)? Possible FraudContact Levi & Korsinsky Today - ACCESS Newswire
Levi & Korsinsky Investigates Exelixis, Inc. (EXEL) Over Possible Securities Fraud - ACCESS Newswire
Exelixis, Inc. (NASDAQ:EXEL) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? - 富途牛牛
Exelixis, Inc. (NASDAQ:EXEL) Shares Sold by Mutual of America Capital Management LLC - Defense World
What Fibonacci levels say about Exelixis Inc. reboundTechnical Long-Term Outlook and Recap Guide - Newser
Momentum Screeners Rank Exelixis Inc. in Top 5 TodaySafe Entry Stock Watch Suggestions for Cautious Traders - beatles.ru
Will Exelixis Inc. continue its uptrendDaily Technical Forecast for Quick Gains - Newser
Is it too late to sell Exelixis Inc.Strategy Builder for Growth Focused Traders - Newser
How to use a screener to detect Exelixis Inc. breakoutsRisk Shielded Trade Watch with Analysis - Newser
Investors in Exelixis, Inc. (EXEL) Warned of Potential Securities FraudContact Levi & Korsinsky Today - ACCESS Newswire
Exelixis, Inc. (EXEL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Signal strength of Exelixis Inc. stock in tech scannersRSI Divergence and Support Breakout Analysis - Newser
Levi & Korsinsky Investigates Possible Securities Fraud by Exelixis, Inc. (EXEL) - ACCESS Newswire
Potential Securities Fraud: Levi & Korsinsky Investigates Exelixis, Inc. (EXEL) - ACCESS Newswire
Exelixis, Inc. (EXEL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Can Exelixis Inc. recover in the next quarterBuy and Hold Strategy for Capital Safety - Newser
Why Exelixis Inc. stock attracts strong analyst attentionFree Optimized Watchlist With Daily Adjustments - Newser
Avantax Advisory Services Inc. Makes New $551,000 Investment in Exelixis, Inc. (NASDAQ:EXEL) - Defense World
Will Exelixis Inc. see short term momentumFundamental Forecast for Undervalued Stocks - Newser
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Exelixis, Inc. (EXEL) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Securities Investigation: Levi & Korsinsky Investigates Exelixis, Inc. (EXEL) on Behalf of Investors - ACCESS Newswire
Exelixis, Inc. : The cure to cancer? - MarketScreener
Cabometyx Sales Miss Mark in Q2: What Does This Mean for EXEL Stock? - TradingView
Exelixis (NASDAQ:EXEL) Cut to “Buy” at Wall Street Zen - Defense World
Exelixis EXEL Q2 2025 Earnings Call Transcript - AOL.com
Bronstein, Gewirtz & Grossman, LLC Encourages Exelixis, Inc. (EXEL) Investors to Inquire about Securities Investigation - ACCESS Newswire
Live market analysis of Exelixis IncReal Time Growth Signal with Smart Setup - Newser
Don't Overlook Exelixis (EXEL) International Revenue Trends While Assessing the Stock - Yahoo Finance
Exelixis Inc. Chart Enters High Volatility ZoneTriple Digit Return Stock Predictions Released - beatles.ru
Exelixis (EXEL) Tumbles 16.8% as Q2 Earnings Disappoint - MSN
How strong is Exelixis Inc. company’s balance sheetBoost your returns with professional guidance - Jammu Links News
What makes Exelixis Inc. stock price move sharplyMassive wealth growth - Jammu Links News
What are analysts’ price targets for Exelixis Inc. in the next 12 monthsSky-high return potential - Jammu Links News
Is Exelixis Inc. a good long term investmentOutstanding trading profits - Jammu Links News
EXEL ALERT: Levi & Korsinsky Investigates Exelixis, Inc. for Possible Securities Fraud Violations - ACCESS Newswire
How does Exelixis Inc. compare to its industry peersBreakthrough capital growth - Jammu Links News
How many analysts rate Exelixis Inc. as a “Buy”Capitalize on market momentum for maximum profit - Jammu Links News
Did You Suffer Losses in Exelixis, Inc. (EXEL)? Contact Levi & Korsinsky About Securities Fraud Claims - ACCESS Newswire
Why is Exelixis Inc. stock attracting strong analyst attentionBreakthrough profit margins - Jammu Links News
What analysts say about Exelixis Inc. stockSuperior investment outcomes - Jammu Links News
What catalysts could drive Exelixis Inc. stock higher in 2025Free Stock Selection - Jammu Links News
Exelixis outlines continued cabozantinib growth and zanzalintinib pipeline acceleration as new launches drive 19% revenue increase - MSN
William Blair Has Positive Forecast for Exelixis Q3 Earnings - Defense World
Does Exelixis Inc. stock perform well during market downturnsRetirement Planning Entry Points For Consistent Profits - Jammu Links News
EXEL ALERT: Levi & Korsinsky Investigates Exelixis, Inc. on Behalf of Shareholders Who Lost Money - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Exelixis, Inc. (EXEL) And Encourages Stockholders to Reach Out - ACCESS Newswire
Exelixis (NASDAQ:EXEL) Price Target Raised to $41.00 - Defense World
Truist Financial Cuts Exelixis (NASDAQ:EXEL) Price Target to $49.00 - Defense World
Exelixis’ (EXEL) Buy Rating Reiterated at Guggenheim - Defense World
Exelixis (NASDAQ:EXEL) Given a $38.00 Price Target by UBS Group Analysts - Defense World
1.02%
3.70%
자본화:
|
볼륨(24시간):